USPTO serial 79306697
CARL SOLUTIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 14, 2022
- Examiner
- BECHHOFER, YOCHEVED D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CARL SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alan E. Schiavelli
Alan E. Schiavelli Fitch, Even, Tabin & Flannery LLP120 South LaSalle StreetSuite 2100Chicago, IL 60603Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and veterinary preparations and articles, namely, for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; pharmaceuticals and natural remedies for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for the purpose of resuscitation; diagnostic preparations for medical and veterinary use for detecting physiological and blood-specific properties of a human or an animal; medical dressings, medical coverings and medical applicators for cover and reseal of wounds and applicators prefilled with medical drugs for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation and or blood for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation or blood substitute for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation; medicines for veterinary purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and resuscitation; biological preparations for medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; biological preparations for veterinary and medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood for medical purposes; blood components for medical purposes for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood substitutes for medical and veterinary use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood plasma; enzymes for veterinary purposes; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; solid oxygen for medical use; gases for medical purposes; gas mixtures for medical use; haemoglobin; cooling sprays for medical purposes; pharmaceutical preparations for veterinary use for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; radioactive substances for medical purposes; solidified gases for medical purposes; veterinary preparations for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation | ACTIVE | — |
| 009 | Measuring, detecting and monitoring instruments, indicators and controllers for measuring, detecting, and monitoring electrical, physiological and chemical properties of biological organism, including a human or an animal for scientific research uses, namely, for measuring, detecting, and monitoring electrical, physiological and chemical properties of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; automatic dosage apparatus, namely, machines for dispensing pre-determined dosages of medication, in particular, medical drugs, and blood or blood substitute for influencing physiological and chemical blood properties; electronic indicator panels for indicating body activity and function of a human or an animal not for medical purposes; electric monitoring units for monitoring body activities of a human or an animal for scientific research uses, namely, for monitoring body activities of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; electric monitoring control apparatus for monitoring and controlling body activity and function of a human or an animal, including cardiac activity for scientific research uses, namely, for and controlling cardiac activity, and body activity and function of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; all the aforesaid goods in this class excluding the use thereof in the field of maintenance management and financial management | ACTIVE | — |
| 010 | Cardio training equipment for physical therapy purposes all designed specifically for medical use, namely, ergometers for medical testing purposes, bicycle ergometers for medical testing purposes, indoor cycles, treadmills, crosstrainers in the nature of ellipticals, rowing machine ergometers for medical purposes, stepper devices; physiotherapy and rehabilitation equipment all designed specifically for medical use, namely, shoulder stretcher using resistance cables, treadmills, stepper, and indoor bicycles; apparatus for the therapeutic stimulation of the muscles, including the heart muscle by applying electrodes on the chest, namely, electronic muscle stimulators for medical purposes; cardio training devices, namely, body rehabilitation apparatus for medical purposes | ACTIVE | — |
| 039 | Rescue of people; rescue services | ACTIVE | — |
| 041 | Training for handling scientific instruments and apparatus for research in laboratories; education services, namely, providing courses of instruction in the field of therapeutic treatments, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of health and safety, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of occupational health, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical education services in the nature of courses of instruction in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; educational services in the nature of courses of instruction in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services for medical visitors in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; teaching services in the nature of courses of instruction in the surgical field, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; education services in the nature of courses of instruction in the field of medicine, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; workshops for educational purposes in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary | ACTIVE | — |
| 044 | Ambulant medical care, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; physician services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical care, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; services for the provision of medical care information, namely, providing information concerning treatment of people suffering cardiac arrest by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical analysis of human tissues for medical treatment; therapeutic treatment of the body in the nature of medical treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; telemedicine services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals used in the treatment of people suffering cardiac arrest, as part of a regimen that includes withdrawing blood from the patient, analyzing and modifying the blood with pharmaceuticals and introducing the modified blood and/or a chosen pharmaceutical substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical and pharmaceutical consultation; physical therapy; emergency medical assistance, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical assistance, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the diagnosis of conditions of the human body, namely, withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the treatment of conditions of the human body, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical evaluation services, namely, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical advisory services, namely, providing medical advice regarding treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing the blood before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical treatment services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; physical rehabilitation; medical health assessment services; medical testing services, namely, medical testing of blood for purposes of introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical clinic services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; surgery, namely, treatment of people suffering cardiac arrest, by surgically withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ResuSciTec GmbH
- Other trademarks owned by ResuSciTec GmbH
- Other trademarks owned by ResuSciTec GmbH
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 039
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named CARL SOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 17, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 23, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 23, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 14, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 14, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 14, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 29, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 9, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 9, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 22, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 22, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 11, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jun 19, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 23, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 22, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |